CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 142 filers reported holding CYMABAY THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,308,097 | +631.5% | 1,026,700 | +327.8% | 0.24% | +490.0% |
| Q1 2023 | $2,092,800 | +75.7% | 240,000 | +26.3% | 0.04% | +122.2% |
| Q4 2022 | $1,191,300 | +242.3% | 190,000 | +90.0% | 0.02% | +350.0% |
| Q3 2022 | $348,000 | -15.5% | 100,000 | -28.6% | 0.00% | -20.0% |
| Q2 2022 | $412,000 | +9.9% | 140,000 | +16.7% | 0.01% | +25.0% |
| Q1 2022 | $375,000 | -40.4% | 120,000 | -33.3% | 0.00% | -80.0% |
| Q2 2020 | $629,000 | +192.6% | 179,900 | +499.7% | 0.02% | +81.8% |
| Q2 2019 | $215,000 | – | 30,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,787,094 | $26,645,572 | 14.80% |
| Lynx1 Capital Management LP | 994,161 | $14,822,941 | 9.80% |
| Octagon Capital Advisors LP | 3,073,750 | $45,829,613 | 7.04% |
| Saturn V Capital Management LP | 1,124,459 | $16,765,684 | 7.02% |
| Altium Capital Management LP | 800,000 | $11,928,000 | 6.22% |
| Affinity Asset Advisors, LLC | 1,129,376 | $16,838,996 | 4.74% |
| ACUTA CAPITAL PARTNERS, LLC | 418,000 | $6,232,380 | 4.18% |
| Cormorant Asset Management, LP | 3,850,000 | $57,403,500 | 3.35% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 590,000 | $8,796,900 | 2.67% |
| MPM BioImpact LLC | 610,770 | $9,106,581 | 2.43% |